Skip to content
★ Sign in to follow
HB
Total declarations
6
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 14 Oct 2022 for GSK plc, €57k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

H Barron: trading record in brief

All filings by H Barron on record concern GSK plc. The record holds 6 filings, for trades running from 22 July 2022 to 12 October 2022.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 14 October 2022, reports a share grant of €57k in GSK plc. Filings reach the RNS (LSE) feed a median of 4 days after the trade. For comparison, UK MAR gives managers three business days to notify a trade. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to H Barron

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ◆
    Non-Executive DirectorExecutivesGSK plc
    55,176 USD0FCA-NSM
    1,803.714 shares@ US$30.59New York Stock Exchange (XNYS)ISIN US37733W2044FCA-NSM:4545204-0
  • ◆
    Non-Executive DirectorExecutivesGSK plc
    37,020 USD0FCA-NSM
    1,234 shares@ US$30.00New York Stock Exchange (XNYS)ISIN US37733W2044FCA-NSM:4543614-2
  • ◆
    Non-Executive DirectorExecutivesGSK plc
    105,956 USD0FCA-NSM
    3,093.611 shares@ US$34.25New York Stock Exchange (XNYS)ISIN US37733W2044FCA-NSM:4483580-0
  • ◆
    Non-Executive DirectorExecutivesGSK plc
    2,089 USD0FCA-NSM
    61 shares@ US$34.25New York Stock Exchange (XNYS)ISIN US37733W2044FCA-NSM:4483580-1
  • ◆
    Non-Executive DirectorExecutivesGSK plc
    51,508 USD0FCA-NSM
    1,277.8 shares@ US$40.31New York Stock Exchange (XNYS)ISIN US37733W2044FCA-NSM:4472718
  • ◆
    Chief Scientific Officer and President, R&DExecutivesGSK plc
    51,508 USD0FCA-NSM
    1,217.974 shares@ US$42.29New York Stock Exchange (XNYS)ISIN US37733W2044FCA-NSM:4456604

6 of 6 declarations